Following the discovery of Carcinoembryonic antigen (CEA or CEACAM5) as a colorectal cancer-associated antigen, anti-CEACAM5 mAbs have been found effective in diagnosis and therapy of multiple types of cancers. This evidence concerns the gene CEACAM5 and cancer.